INBX Buy Disclosure
Kayyem Jon Faiz · SEC Form 4 · Filed Sep 8, 2026
Buy
Calculated transaction value
$567.58K
Kayyem Jon Faiz Director
INBX
Inhibrx Biosciences
INBX
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
INBX daily price context
Close on/before transaction
$114.34
Sep 8, 2026
Close before public filing
$123
Sep 7, 2026
Return since public filing
-11.1%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $113.52
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001366268-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$567.58K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Inhibrx Biosciences, Inc. INBX Current | Buy | Sep 8, 2026 | $567.58K |